The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[2-(tert-butylamino)-1-[[4-[(4-chloro-2-methyl-anilino)methyl]phenyl]methyl-formyl-amino]-2-oxo-ethyl]-6-chloro-1H-indole-2-carboxylic acid ID: ALA5273558
Chembl Id: CHEMBL5273558
Max Phase: Preclinical
Molecular Formula: C31H32Cl2N4O4
Molecular Weight: 595.53
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(Cl)ccc1NCc1ccc(CN(C=O)C(C(=O)NC(C)(C)C)c2c(C(=O)O)[nH]c3cc(Cl)ccc23)cc1
Standard InChI: InChI=1S/C31H32Cl2N4O4/c1-18-13-21(32)10-12-24(18)34-15-19-5-7-20(8-6-19)16-37(17-38)28(29(39)36-31(2,3)4)26-23-11-9-22(33)14-25(23)35-27(26)30(40)41/h5-14,17,28,34-35H,15-16H2,1-4H3,(H,36,39)(H,40,41)
Standard InChI Key: FGYLISBTHFRGGY-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 595.53Molecular Weight (Monoisotopic): 594.1801AlogP: 6.71#Rotatable Bonds: 10Polar Surface Area: 114.53Molecular Species: ACIDHBA: 4HBD: 4#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.85CX Basic pKa: 3.25CX LogP: 4.87CX LogD: 2.22Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.15Np Likeness Score: -1.15
References 1. Zhang S, Lou J, Li Y, Zhou F, Yan Z, Lyu X, Zhao Y.. (2021) Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions., 64 (15.0): [PMID:34286973 ] [10.1021/acs.jmedchem.1c00940 ]